|
|
|
|
Archives
|
Entry
|
Author
|
Date
|
Location
|
|
Cell Therapeutics Pulls FDA Application, Saying It Isn’t Ready For Panel
|
Luke Timmerman |
01/30/12 |
Seattle
|
|
The Year in Seattle Biotech: Lots of Acquisitions, Few New Startups
|
Luke Timmerman |
12/22/11 |
Seattle
|
|
Theraclone Nabs Big Pfizer Deal, Dendreon Pockets $540M, Seattle Genetics’ Close-Up, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
01/20/11 |
Seattle
|
|
Cell Therapeutics Snags $25M
|
Luke Timmerman |
01/13/11 |
Seattle
|
|
Cell Therapeutics Seeks EU Approval
|
Luke Timmerman |
11/01/10 |
Seattle
|
|
Intellectual Ventures’ Med-Tech Foray, PATH Takes Ultra Rice to Africa, Mirador Gets FDA OK, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
10/21/10 |
Seattle
|
|
Cell Therapeutics Adds $21M
|
Luke Timmerman |
10/20/10 |
Seattle
|
|
Lee Hartwell’s Next Career Move, Swedish’s Social Media Ace, Cell Therapeutics’ Lifeline, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
09/23/10 |
Seattle
|
|
Cell Therapeutics Finds Way to Survive, Persuading Investors to OK Sale of 400M Shares
|
Luke Timmerman |
09/16/10 |
Seattle
|
|
Biotech Drug Discovery in Seattle: A Look Back
|
Stewart Lyman |
06/11/10 |
Seattle
|
|
Seattle Genetics Grows Up Fast, Valocor Seeks to Fight Acne, Cell Therapeutics Nabs $21M & More Seattle-Area Life Sciences News
|
Luke Timmerman |
05/27/10 |
Seattle
|
|
Cell Therapeutics Adds $21M
|
Luke Timmerman |
05/24/10 |
Seattle
|
|
AVI Biopharma Ousts CEO, CombiMatrix Drops Seattle Wing, Cell Therapeutics Cans 36 Workers, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
04/22/10 |
Seattle
|
|
Cell Therapeutics Cuts 36 Employees
|
Luke Timmerman |
04/15/10 |
Seattle
|
|
Dendreon’s Pricing Question, UW’s $300M Stimulus Windfall, Cell Therapeutics Rejected by FDA, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
04/15/10 |
Seattle
|
|
Cell Therapeutics Shareholder Meeting Postponed, After FDA Rejection
|
Luke Timmerman |
04/09/10 |
Seattle
|
|
Cell Therapeutics Lymphoma Drug Fails to Win FDA Approval
|
Luke Timmerman |
04/09/10 |
Seattle
|
|
Our Top 20 Stories of the First Quarter: Amazon, Cell Therapeutics, Dendreon, Microsoft, and More
|
Gregory T. Huang |
04/02/10 |
Seattle
|
|
FDA Panel Slams Cell Therapeutics, Oncothyreon Slumps, Biotech’s Healthcare Victory, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
03/25/10 |
Seattle
|
|
Cell Therapeutics Looks to Pick up the Pieces After FDA Smacks Down Lymphoma Drug
|
Luke Timmerman |
03/23/10 |
Seattle
|
|
Cell Therapeutics Shares Crash as Lymphoma Drug Gets Shot Down by FDA Panel
|
Luke Timmerman |
03/22/10 |
Seattle
|
|
FDA Cancer Drug Boss Slams Cell Therapeutics Application For Lymphoma Drug
|
Luke Timmerman |
03/22/10 |
Seattle
|
|
Cell Therapeutics FDA Panel Primer: Take Two
|
Luke Timmerman |
03/19/10 |
Seattle
|
|
Cell Therapeutics Passes Factory Test
|
Luke Timmerman |
03/08/10 |
Seattle
|
|
Cell Therapeutics Offers Execs Big Cash Bonuses As Stock Trades Below a Buck
|
Luke Timmerman |
03/05/10 |
Seattle
|
|
The Pharmaceutical R&D Model is Broken. Here’s How to Fix It
|
Stewart Lyman |
03/05/10 |
Seattle
|
|
Dendreon’s False Rumor, Cell Therapeutics’ New FDA Day, Microsoft’s Health-IT Plan, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
03/04/10 |
Seattle
|
|
Cell Therapeutics Gets New Day in Front of FDA
|
Luke Timmerman |
03/01/10 |
Seattle
|
|
Cell Therapeutics Panel Stalled, Medical Device Angels Band Together, Calypso Cuts Side Effects, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
02/18/10 |
Seattle
|
|
Cell Therapeutics Shares Fall as FDA Says Lymphoma Drug Has “Substantial” Side Effects
|
Luke Timmerman |
02/08/10 |
Seattle
|
|
Page 1 of
4 |
next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.